Liver Diseases  >>  MitoQ (mitoquinone)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MitoQ (mitoquinone) / Antipodean
MARVEL, NCT01167088 / 2010-021368-13: A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)

Terminated
2
110
Europe
Mitoquinone mesylate, Placebo
Antipodean Pharmaceuticals, Inc.
Non-alcoholic Fatty Liver Disease
06/11
07/11

Download Options